Serological Analysis to Delineate Between Gastric Atrophy and a Normal Health Stomach without Endoscopy

Download Article

Authors : Stephen Joseph Atta Mensah


The article "Serological Assessment of Samples from Patients Complaining of Dyspepsia" by Dr. Stephen Mortlock is current article published in the Journal of Gastrointestinal and Digestive Systems in October 2013. This review analyses the article's structure, authority, currency, stability, objectivity and it relevance to students and the health care industry. The review first summarize the article. it then analysis the structure of the article, taking into consideration the concept, methodology of the research, it accessible and the technical flow of the article. The review will also critique the article on the basis of its authority, currency, accuracy, objectivity and it stability. The relevance of the article to in the academia and healthcare industry will also be analyzed in the review. The review will analyze all the relevant data and information (including diagrams) provided by the article before judging on the credibility and the reliability of the article. In entirety, the article is very well written, well structured, clear and relevant in to first year medical students and general practitioners.


[1.] Agréus, L., Kuipers, EJ., Kupcinskas, L., Malfertheiner, P., & Di Mario, F., et al (2012). Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 47: 136-147.

[2.] Agréus, L., Kuipers, EJ., Kupcinskas, L., Malfertheiner, P., & Di Mario, F., et al. (2012). Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 47: 136-147.

[3.] Axon, A.,(2002) Management of uninvestigated dyspepsia: review and commentary. Gut 50 Suppl 4: iv51-55.

[4.] Brun, R., & Kuo, B., (2010). Functional dyspepsia. Therap Adv Gastroenterol 3: 145-164.

[5.] Dai, YC., Tang, ZP.,& Zhang ,YL (2011). How to assess the severity of atrophic gastritis. World J Gastroenterol 17: 1690-1693.

[6.] ErdoÄŸan, A.,& Yilmaz, U., (2011). Is there a relationship between Helicobacter pylori and gastric autoimmunity? Turk J Gastroenterol 22: 134-138.

[7.] Harmon, RC., & Peura, DA., (2010). Evaluation and management of dyspepsia. Therap Adv Gastroenterol 3: 87-98.

[8.] Iijima, K., Abe, Y., Kikuchi, R., Koike, T., & Ohara, S., et al. (2009). Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 15: 853-859.

[9.] Kamangar, F., Sheikhattari, P., & Mohebtash, M., (2011). Helicobacter pylori and its effects on human health and disease. Arch Iran Med 14: 192-199.

[10.]   Mason, JM., Delaney, B., Moayyedi, P., Thomas, M.,& Walt, R., et al. (2005). Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 21: 1135-1143.

[11.]   Mortlock, S., Nikulin, M., & Arnold-Maclean, C., (2012). ‘External quality assessment of a non-standard gastric assay panel.’ The Biomedical Scientist 56: 533-534.

[12.]   Nasrollahzadeh, D., Aghcheli, K., Sotoudeh, M., Shakeri, R., & Persson,EC., et al. (2011). Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One 6: e26957.

[13.]   Oustamanolakis, P.,& Tack, J., (2012). Dyspepsia: organic versus functional. J Clin Gastroenterol 46: 175-190.

[14.]   Penston, JG., & Pounder, RE., (1996). A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 10: 83-89.

[15.]   Spiegel, BM., Vakil, NB., & Ofman, JJ., (2002) Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 122: 1270-1285.

[16.]   Sudraba, A., Daugule, I., Rudzite, D., Funka, K., & Tolmanis, I., et al. (2011). Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. J Gastrointestin Liver Dis 20: 349-354.

[17.]   Sugano, K .,(2011). Should we still subcategorize helicobacter pylori-associaed dyspepsia as functional disease? J Neurogastroenterol Motil 17: 366-371.

[18.]   Taniyama, K., Shimbo, T., Iwase, H., Tanaka, S., & Watanabe, N., et al. (2011). Evidence-based therapy according to the guideline for gastric ulcers is cost-effective in Japan. J Physiol Pharmacol 62: 627-635.

[19.]   Wallander, MA., Johansson, S., Ruigómez, A., García Rodríguez, LA., & Jones, R., (2007). Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 24: 403-411.

[20.]   Yakoob, J., Abbas, Z., Khan, R., Naz, S., & Ahmad, Z., et al. (2012). Prevalence of non Helicobacter pylori species in patients presenting with dyspepsia. BMC Gastroenterol 12: 3.